Rubio, Neus Domper

SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 132-134

10.1002/hon.93_2629